Paper8622178
Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria.
Merchat M and 4 others. J Photochem Photobiol B, 1996. Cited by 260 papers, by iCite.
Cite this record
ConductScience Library. Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. Papers, record 8622178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8622178
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gram-Negative Bacteria | Major topic |
| Gram-Positive Bacteria | Major topic |
| Indoles | Major topic |
| Photosensitizing Agents | Major topic |
| Porphyrins | Major topic |
| Dose-Response Relationship, Radiation | |
| Enterococcus | |
| Escherichia coli | |
| Isoindoles | |
| Light | |
| Structure-Activity Relationship | |
| Vibrio |
Source PubMed
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 260 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42705845 | Effects of Mono- and Dicapsaicinoid Functionalization on the Physicochemical Properties and Antimicrobial Photodynamic Activity of Protoporphyrin IX. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42705845 | PubMed |
| 42360110 | Enhancing the Antimicrobial Photodynamic Activity of Heteroleptic Ruthenium(II) Complexes: Role of Asymmetric N-Donor-Based Ligands. | Inorg Chem | 2026 | https://conductscience.org/library/papers/42360110 | PubMed |
| 40703980 | Photodynamic therapy and peri-implant diseases: a systematic review and meta-analysis. | Front Oral Health | 2025 | https://conductscience.org/library/papers/40703980 | PubMed |
| 40358765 | Optimizing of photodynamic parameters: determining the key factors for effective inactivation of Streptococcus mutans biofilms with phycocyanin. | Lasers Med Sci | 2025 | https://conductscience.org/library/papers/40358765 | PubMed |
| 39011148 | Pistacia vera L. as natural source against antimicrobial and antiviral resistance. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39011148 | PubMed |
| 38734995 | Photodynamic inactivation of E. coli with cationic imidazolyl-porphyrin photosensitizers and their synergic combination with antimicrobial cinnamaldehyde. | Photochem Photobiol Sci | 2024 | https://conductscience.org/library/papers/38734995 | PubMed |
| 38619253 | Evaluation and activity of new porphyrin-peptide cage-type conjugates for the photoinactivation of Mycobacterium abscessus. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38619253 | PubMed |
| 38132458 | Cationic Porphyrins as Antimicrobial and Antiviral Agents in Photodynamic Therapy. | Curr Issues Mol Biol | 2023 | https://conductscience.org/library/papers/38132458 | PubMed |
| 38113026 | Optimal effective concentration combinations (OPECCs) for binary application of membrane-targeting antiseptics and TMPyP-mediated antimicrobial photodynamic therapy. | Photochem Photobiol Sci | 2024 | https://conductscience.org/library/papers/38113026 | PubMed |
| 38051456 | Photophysical, photobiological, and mycobacteria photo-inactivation properties of new meso-tetra-cationic platinum(II) metalloderivatives at meta position. | Braz J Microbiol | 2024 | https://conductscience.org/library/papers/38051456 | PubMed |
| 37661273 | Polyurethane-based nanofibrous mat containing porphyrin with photosensitivity and bactericidal properties can promote cutaneous tissue healing in rats. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37661273 | PubMed |
| 37425217 | Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper. | J Porphyr Phthalocyanines | 2020 | https://conductscience.org/library/papers/37425217 | PubMed |
| 36903314 | Sulfonamide Porphyrins as Potent Photosensitizers against Multidrug-Resistant Staphylococcus aureus (MRSA): The Role of Co-Adjuvants. | Molecules | 2023 | https://conductscience.org/library/papers/36903314 | PubMed |
| 36712647 | Macrophage-targeted nanoparticles mediate synergistic photodynamic therapy and immunotherapy of tuberculosis. | RSC Adv | 2023 | https://conductscience.org/library/papers/36712647 | PubMed |
| 36545324 | Influence of silver ion release on the inactivation of antibiotic resistant bacteria using light-activated silver nanoparticles. | Mater Adv | 2022 | https://conductscience.org/library/papers/36545324 | PubMed |
| 36515881 | Porphyrins developed for photoinactivation of microbes in wastewater. | Environ Sci Pollut Res Int | 2023 | https://conductscience.org/library/papers/36515881 | PubMed |
| 35164334 | Preliminary Studies of Antimicrobial Activity of New Synthesized Hybrids of 2-Thiohydantoin and 2-Quinolone Derivatives Activated with Blue Light. | Molecules | 2022 | https://conductscience.org/library/papers/35164334 | PubMed |
| 34300985 | Photodynamic Inactivation of Pseudomonas aeruginosa by PHEMA Films Loaded with Rose Bengal: Potentiation Effect of Potassium Iodide. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/34300985 | PubMed |
| 34203767 | Derivatives of Natural Chlorophylls as Agents for Antimicrobial Photodynamic Therapy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34203767 | PubMed |
| 34055830 | Factors Determining the Susceptibility of Bacteria to Antibacterial Photodynamic Inactivation. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34055830 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8622178
GET https://conductscience.org/api/papers/v1/8622178/cited_by?page=2